Showing results (51-60 of 148) with videos related to

Sort By:
Pageof 15
Epigenetics|November 3, 2012
Modifying metabolically sensitive histone marks by inhibiting glutamine metabolism affects gene expression and alters cancer cell phenotypeNatalie E Simpson, Volodymyr P Tryndyak, Marta Pogribna, et al.
Epigenetics|October 30, 2007
Global leukocyte DNA methylation is similar in African American and Caucasian women under conditions of controlled folate intakeJuan Axume, Steven S Smith, Igor P Pogribny, et al.
Toxicology|March 13, 2017
miR-1247 blocks SOX9-mediated regeneration in alcohol- and fibrosis-associated acute kidney injury in miceKostiantyn Dreval, Aline de Conti, Shinji Furuya, et al.
Archives of Toxicology|August 27, 2020
Epigenetic effects of low-level sodium arsenite exposure on human liver HepaRG cellsVolodymyr P Tryndyak, Barbara Borowa-Mazgaj, Colleen R Steward, et al.
Clinical Epigenetics|September 28, 2011
MicroRNA-mediated drug resistance in breast cancerKristy R Kutanzi, Olga V Yurchenko, Frederick A Beland, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|August 30, 2018
Effect of aflatoxin B1, benzo[a]pyrene, and methapyrilene on transcriptomic and epigenetic alterations in human liver HepaRG cellsVolodymyr Tryndyak, Iryna Kindrat, Kostiantyn Dreval, et al.
The Journal of Nutrition|November 11, 2003
Mechanisms of DNA damage, DNA hypomethylation, and tumor progression in the folate/methyl-deficient rat model of hepatocarcinogenesisS Jill James, Igor P Pogribny, Marta Pogribna, et al.
Mutation Research|March 9, 2007
Induction of microRNAome deregulation in rat liver by long-term tamoxifen exposureIgor P Pogribny, Volodymyr P Tryndyak, Alex Boyko, et al.
Carcinogenesis|September 2, 2003
Methyl deficiency causes reduction of the methyl-CpG-binding protein, MeCP2, in rat liverFarah Esfandiari, Ralph Green, Rebecca F Cotterman, et al.
International Journal of Cancer|January 26, 2010
Alterations of microRNAs and their targets are associated with acquired resistance of MCF-7 breast cancer cells to cisplatinIgor P Pogribny, Jody N Filkowski, Volodymyr P Tryndyak, et al.
Pageof 15